SCHEMBL7726489

SCHEMBL7726489

C=CCNCC(=O)Nc1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
RAB9A P51151 4/20 0.59
HPGD P15428 3/20 0.59
KDM4E B2RXH2 1/20 0.58
LMNA P02545 2/20 0.57
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
NPC1 O15118 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.51
MAPT P10636 2/20 0.50
NPY5R Q15761 2/20 0.49
FFAR1 O14842 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPK13 O15264 1/20 0.47
MAPK12 P53778 1/20 0.47
MAPK11 Q15759 1/20 0.47
MAPK14 Q16539 1/20 0.47
HDAC1 Q13547 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8520467 0.88 KDM4E (0.59) KDM4EMEN1KMT2AL3MBTL1MAPT
Benzophenone SCHEMBL7590791 0.82 ALDH1A1 (0.69) ALDH1A1RAB9AHPGDKDM4ELMNA
SCHEMBL11784730 0.77 ALDH1A1 (0.62) ALDH1A1RAB9AHPGDKDM4ELMNA
SCHEMBL4413289 0.76 KDM4E (0.60) ALDH1A1RAB9AHPGDKDM4ELMNA
SCHEMBL7735715 0.75 ALDH1A1 (0.67) ALDH1A1RAB9AHPGDMEN1KMT2A
SCHEMBL39036 0.74 TGM2 (0.72) ALDH1A1RAB9AHPGDLMNAMEN1
SCHEMBL11789125 0.74 ALDH1A1 (0.70) ALDH1A1RAB9AHPGDLMNAMEN1
SCHEMBL13652520 0.74 ALDH1A1 (1.00) ALDH1A1RAB9AHPGDKDM4ELMNA
SCHEMBL12263890 0.74 ALDH1A1 (0.70) ALDH1A1RAB9AHPGDLMNAMEN1
SCHEMBL10813985 0.74 ALDH1A1 (0.70) ALDH1A1RAB9AHPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410792-B1 OBESITY DISEASES BAYER CORPORATION 2002-06-25 US disclosed
US-6048900-A FOR TREATING EATING DISORDERS, INSULIN RESISTANT DIABETES, HYPERTENSION, HYPERLIPEMIA BAYER CORPORATION (US) 2000-04-11 US disclosed